血清S100A9预测依那西普疗效在英国大型类风湿关节炎队列中未获证实
本研究在英国236例即将开始依那西普治疗的类风湿关节炎患者中,用ELISA检测治疗前血清S100A9浓度,并按EULAR反应评估疗效。多因素logistic回归未发现S100A9浓度与EULAR反应相关,与疾病活动度临床指标也无显著关联,不支持将其作为预测依那西普反应的临床生物标志物。
要点
- 治疗前血清S100A9浓度与依那西普EULAR反应无显著关联。
- S100A9与疾病活动度临床指标之间亦无显著相关。
- 这是目前规模最大的验证队列,结果未支持S100A9的预测价值。
核心结论
- 在英国大型验证队列中,未观察到支持血清S100A9作为预测依那西普(TNF抑制剂)反应临床生物标志物的证据。
研究设计与样本
- 英国验证队列,纳入即将开始依那西普治疗的类风湿关节炎患者236例。
- 用ELISA检测治疗前血清S100A9浓度,并按EULAR反应分析其关联。
主要发现
- 多因素logistic回归显示S100A9浓度与EULAR反应无关联:无反应者 vs 中等反应者 P = 0.957。
- 无反应者 vs 良好反应者 P = 0.316。
- 治疗前S100A9浓度与疾病活动度临床参数的相关性均不显著(P > 0.05)。
临床怎么用
- 不宜依据治疗前血清S100A9浓度预测类风湿关节炎患者对依那西普的EULAR反应。
- 选择TNF抑制剂前仍需依赖现有临床评估与常规指标,而非S100A9检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim was to correlate protein concentrations of S100A9 in pretreatment serum samples with response to the tumour-necrosis factor (TNF) inhibitor drugs etanercept in a large UK replication cohort. METHODS: Pretreatment serum samples from patients with RA (n = 236) about to commence treatment with etanercept had S100A9 serum concentration measured using an ELISA. Following the experimental procedure, S100A9 concentrations were analysed with respect to EULAR response. RESULTS: No evidence of association between S100A9 concentration and EULAR response to the TNF-inhibitor biologic drug etanercept was observed following multinomial logistic regression analysis (non-responder vs moderate responder, P = 0.957; and non-responder vs good responder, P = 0.316). Furthermore, no significant associations were observed when correlating pretreatment S100A9 concentrations with clinical parameters of disease activity (P > 0.05). CONCLUSION: In the largest replication cohort conducted to date, no evidence for association was observed to support the use of S100A9 as a clinical biomarker predictive of response to the TNF-inhibitor biologic drug etanercept.
引用
- Smith SL, Plant D, Eyre S, et al. The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohort. Rheumatology (Oxford). 2017. PMID: 28096457. doi:10.1093/rheumatology/kew387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。